Menu

 

All Sites Sorted » Health Beauty and Fitness » Medicine


 


Sponsored

 

Latest News

Tetraphase Pharmaceuticals Announces Positive Oral Dosing Data from Lead-in of IGNITE 2 Phase 3 Trial of Eravacycline ...
Tetraphase Pharmaceuticals, Inc. today announced that positive top-line results from the lead-in portion of its IGNITE 2 clinical trial, a two-part Phase 3 clinical t Tue, 02 Sep 2014 13:01:00 -0700

Peregrine Pharmaceuticals to Report First Quarter Fiscal Year 2015 Financial Results After Market Close on September 9 ...
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer, today announced that it will report financial results ... Tue, 02 Sep 2014 13:00:00 -0700

ACADIA Pharmaceuticals Receives FDA Breakthrough Therapy Designation for NUPLAZID™ (Pimavanserin) for Parkinson’s ...
ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders, today announced that the U.S. Tue, 02 Sep 2014 06:00:00 -0700

Galleon Pharmaceuticals Announces Publication of Proof-of-Concept Clinical Studies for GAL-021, Projected Use for the ...
Galleon Pharmaceuticals announced clinically and statistically significant results from a double-blind, placebo-controlled clinical proof-of-concept study of its lead investigational compound GAL-021 in normal volunteers. Tue, 02 Sep 2014 06:00:00 -0700

OncoMed Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
REDWOOD CITY, Calif. -- OncoMed Pharmaceuticals, Inc. , a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that Paul ... Tue, 02 Sep 2014 05:30:00 -0700

Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension
SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that the US Food and Drug Administration (FDA) has granted orphan drug status to APD811 for the treatment of pulmonary arterial hypertension. "The FDA Office of Orphan Products Development (OOPD) evaluates scientific and clinical data submissions from sponsors to identify and designate drug candidates ... Tue, 02 Sep 2014 05:00:00 -0700

Portola Pharmaceuticals to Present at the 2014 Morgan Stanley Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif. -- Portola Pharmaceuticals today announced that William Lis, chief executive officer, will present at the 2014 Morgan Stanley Global Healthcare Conference on Tuesday, September ... Tue, 02 Sep 2014 05:00:00 -0700

Tokai Pharmaceuticals Appoints Lee Kalowski as Chief Financial Officer
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases, today announced the appointment of Lee Kalowski as chief financial officer, effective immediately. Tue, 02 Sep 2014 05:00:00 -0700

Cyclacel Pharmaceuticals to Present at 16th Rodman & Renshaw Annual Global Investment Conference
BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of cell ... Tue, 02 Sep 2014 04:00:00 -0700

Spectrum Pharmaceuticals to Present Corporate Update at the Morgan Stanley Global Healthcare Conference in New York ...
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Morgan Stanley Global Healthcare Conference being held at the Grand Hyatt in New York City. Tue, 02 Sep 2014 04:00:00 -0700

Website Directory Sort by: Hits | Alphabetical

Features

Top 5 Web Hosts
(Largest)


Top 5 Favorite Web Hosts

   1. HostGator
   2. LunarPages
   3. Yahoo! Web Hosting
   4. HostMonster
   5. BlueHost